GlassScriptPhysician profile
Ronald G Christopher
NPI 1467403386
$9,070.40
in general payments reported to CMS, 2019-2025
30 companies · $880 in 2025
The $880 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,018 · 2020: $253 · 2021: $336 · 2022: $403 · 2023: $1,458 · 2024: $2,723 · 2025: $880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,787 · Food and Beverage: $2,274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,787.19 |
| Food and Beverage | $2,274.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,350.69 | 2019-2025 | |
| Smoky Mountain Surgical LLC | $1,541.07 | 2023-2025 | |
| Alpha Orthopedic Systems | $1,391.26 | 2019-2023 | |
| Smith+Nephew, INC. | $1,276.23 | 2019-2025 | Stravix Pl, Oasis, Grafix Pl |
| Radius Health, INC. | $343.48 | 2019-2024 | Tymlos |
| Stryker Corporation | $302.78 | 2022-2024 | Tritanium |
| Amgen INC. | $180.59 | 2019-2024 | Evenity, Prolia |
| Medartis INC. | $99.83 | 2019-2020 | |
| Allergan, INC. | $66.68 | 2020-2022 | |
| Abbott Laboratories | $59.41 | 2025 | Eterna |
| Vericel Corporation | $36.24 | 2022 | |
| Depuy Synthes Sales INC. | $32.53 | 2022 | |
| Alexion Pharmaceuticals, INC. | $31.01 | 2023-2024 | Strensiq |
| Fidia Pharma USA INC. | $29.13 | 2022 | |
| Pacira Therapeutics, INC. | $27.06 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $26.08 | 2023 | Seglentis |
| Horizon Therapeutics Plc | $23.92 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $23.35 | 2024 | Tricera Handpiece |
| Abbvie INC. | $22.59 | 2022 | |
| Axogen | $22.20 | 2019 | |
| Heron Therapeutics, INC. | $21.82 | 2021 | |
| Boston Scientific Corporation | $21.13 | 2021 | |
| Orthofix Medical, INC. | $21.08 | 2021-2024 | Accelstim, Physio-Stim |
| Djo, LLC | $19.46 | 2025 | Cmf |
| Pacira Pharmaceuticals Incorporated | $19.23 | 2025 | Zilretta |
| Ucb, INC. | $18.22 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $18.08 | 2025 | |
| Convatec INC. | $17.76 | 2021 | |
| Kci USA, INC. | $15.41 | 2020 | |
| Bioventus LLC | $12.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Christopher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.